Home / Vagitocin®

Vagitocin® – in clinical development for menopausal women


Vagitocin® is a developmental pharmaceutical preparation for the treatment of vaginal atrophy. The product is based on oxytocin, a natural substance, which is produced in the body and which has been used to promote labour and breast-feeding since the beginning of the 1960ies.

Local application of Vagitocin® in the vagina has been shown to rejuvenate the vaginal mucosa.

Learn more about oxytocin, vaginal atrophy and the clinical development of Vagitocin® via the headings in the left column.

NOTE! Vagitocin® is not yet approved as a drug

Kerstin Uvnäs Moberg and Oxytocin

Kerstin_UvnasMoberg_200px Kerstin Uvnäs Moberg is the person behind the oxytocin research that is the foundation of PEPTONIC medical's products. Kerstin speaks on oxytocin » Book-on-Oxytocin New book on Oxytocin by Prof. Kerstin Uvnäs Moberg released »  

Subscribe for press releases

Would you like to receive press releases and news from PEPTONIC Medical straight to your email? Register for our newsletter service on aktietorget.se.

Subscribe for press releases and news »